Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.82 USD | -3.22% | -1.26% | -31.64% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Collaborative Arrangements
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 46 | 21-12-05 |
Marcel Moulaison
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Chief Tech/Sci/R&D Officer | 65 | 19-01-27 | |
Greg Martini
IRC | Investor Relations Contact | - | 17-05-31 |
Susanna H. Huh
PRN | Corporate Officer/Principal | - | 22-08-31 |
Mike Nanfito
SAM | Sales & Marketing | - | 12-04-30 |
John Minardo
LAW | General Counsel | 49 | 21-08-02 |
Ronald Silver
AUD | Comptroller/Controller/Auditor | 42 | 18-05-31 |
Andrew Davis
PRN | Corporate Officer/Principal | 38 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Denner
BRD | Director/Board Member | 54 | 20-11-08 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-12-02 |
Mark Currie
BRD | Director/Board Member | 69 | 19-12-31 |
Andrew Dreyfus
BRD | Director/Board Member | 65 | 16-03-31 |
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Director/Board Member | 64 | 19-03-31 | |
Julie McHugh
CHM | Chairman | 59 | 14-01-31 |
Jon Duane
BRD | Director/Board Member | 65 | 19-03-31 |
Marla Kessler
BRD | Director/Board Member | 54 | 19-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 158,957,123 | 153,278,890 ( 96.43 %) | 0 | 96.43 % |
Company contact information
Ironwood Pharmaceuticals, Inc.
100 Summer Street Suite 2300
02110, Boston
+617 621 7722
http://www.ironwoodpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.64% | 1.24B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IRWD Stock
- Company Ironwood Pharmaceuticals, Inc.